Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

10 Results

Guidelines and Advice

Chemotherapy (i.e., Gemcitabine, Docetaxel Plus Gemcitabine, Doxorubicin, or Trabectedin) for Inoperable, Locally Advanced, Recurrent, or Metastatic Uterine Leiomyosarcoma

Status: Archived
ID: GL 11-11

Jul 2012

Guidelines and Advice

Safe Administration of Chemotherapy: Safety During Chemotherapy Ordering, Transcribing, Dispensing, and Patient Identification

Status: In-Review
ID: 12-12-1

Jul 2012

Guidelines and Advice

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Status: Archived
ID: 12-3

Jan 2003

Guidelines and Advice

Safe Administration of Chemotherapy: Methods and Development

Status: In-Review
ID: 12-12M

Jul 2012

Guidelines and Advice

Radiotherapy Fractionation for the Palliation of Uncomplicated Painful Bone Metastases

Status: Archived
ID: 13-2

Mar 2003

Guidelines and Advice

The Treatment of Lymphedema Related to Breast Cancer

Status: Archived
ID: 13-1

Aug 2003

Guidelines and Advice

Hyperfractionated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Status: Archived
ID: 5-6b

Jan 2003

Statistical Reports

News & Information on Nutrition & Cancer Prevention

Dec 2003

Statistical Reports

News & Information on Prostate Cancer

May 2003

Cancer facts

High Smoking and Obesity Rates Causing Increased Cancer Risk in Ontario Métis

Jul 2012